Application Sponsors
ANDA 207266 | BAXTER HLTHCARE CORP | |
Marketing Status
Application Products
001 | INJECTABLE;SPINAL | 0.75% | 0 | BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2016-07-25 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
BAXTER HLTHCARE CORP
cder:Array
(
[0] => Array
(
[ApplNo] => 207266
[companyName] => BAXTER HLTHCARE CORP
[docInserts] => ["",""]
[products] => [{"drugName":"BUPIVACAINE HYDROCHLORIDE","activeIngredients":"BUPIVACAINE HYDROCHLORIDE","strength":"0.75%","dosageForm":"INJECTABLE;SPINAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"07\/25\/2016","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2016-07-25
)
)